Finance

Lists
Why is 1PFE down २.३२%?
Dive Deeper
1PFE:BIT
Pfizer Inc
€ २४.६४
-२.३२%
(-०.५९) 1D
अक्टोबर २, १७:३५:१४ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1PFE...
Open
€ २५.०४
High
€ २५.०८
Low
€ २४.६०
Mkt. cap
१.६१ खरब
Avg. vol.
६.४४ हजार
Volume
२.९४ हजार
52-wk high
€ २५.५०
52-wk low
€ २०.४५
No. of employees
७५ हजार
Open
€ २५.०४
High
€ २५.०८
Low
€ २४.६०
Mkt. cap
१.६१ खरब
Avg. vol.
६.४४ हजार
Volume
२.९४ हजार
52-wk high
€ २५.५०
52-wk low
€ २०.४५
No. of employees
७५ हजार
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
३ घण्टा पहिले
Pfizer Inc. stock at EUR 25.21, up 18.0 percent year to date
Business Model Analyst
Business Model Analyst
·
८ घण्टा पहिले
Pfizer Handed AI to Its Business Leaders. Adoption Sped Up
Yahoo Finance
Yahoo Finance
·
९ घण्टा पहिले
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOAlbert Bourla
Employees७५ हजार
Founded१८४९
Headquartersन्यू योर्क शहर, न्यू योर्क, संयुक्त राज्य अमेरिका
Sector-
Websitepfizer.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१६.६५ अरब
१७.५६ अरब
१४.४५ अरब
१५.०३ अरब
Cost of goods sold
३.९८ अरब
५.०६ अरब
३.४१ अरब
३.६६ अरब
Cost of revenue
३.९८ अरब
५.०६ अरब
३.४१ अरब
३.६६ अरब
Research and development expenses
२.४९ अरब
३.३२ अरब
२.४५ अरब
२.७५ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.०८ अरब
३.७४ अरब
२.८४ अरब
३.२६ अरब
Operating expense
६.८० अरब
८.२९ अरब
६.४८ अरब
७.१९ अरब
Total operating expenses
१०.७८ अरब
१३.३५ अरब
९.८८ अरब
१०.८४ अरब
Operating income
५.८८ अरब
४.२० अरब
४.५७ अरब
४.१९ अरब
Other non operating income
१८.१० करोड
१.३५ अरब
३.६० करोड
५१.५० करोड
EBT including unusual items
३.३३ अरब
-१.६४ अरब
३.१७ अरब
-६५.३० करोड
EBT excluding unusual items
५.५४ अरब
५.०९ अरब
४.१३ अरब
४.२५ अरब
Income tax expense
-२१.६० करोड
-२०.०० लाख
४६.१० करोड
-४०.७० करोड
Effective tax rate
-६.४८%
०.१२%
१४.५५%
६२.३३%
Other operating expenses
-
-
-
-
Net income
३.५४ अरब
-१.६५ अरब
२.६९ अरब
-२४.८० करोड
Net profit margin
२१.२६%
-९.३९%
१८.५९%
-१.६५%
Earnings per share
०.८७
०.६६
०.७५
०.७७
Interest and investment income
१३.८० करोड
२४.७० करोड
१९.७० करोड
२१.१० करोड
Interest expense
-६५.२० करोड
-७१.१० करोड
-६६.८० करोड
-६६.७० करोड
Net interest expenses
-५१.४० करोड
-४६.४० करोड
-४७.१० करोड
-४५.६० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
७.५३ अरब
५.८६ अरब
६.१८ अरब
५.८० अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू